KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Cash from Operations Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4.72%
Dec 31, 2025 1.46%
Sep 30, 2025 3.80%
Jun 30, 2025 10.78%
Mar 31, 2025 -15.59%
Dec 31, 2024 16.57%
Sep 30, 2024 3.64%
Jun 30, 2024 -1.72%
Mar 31, 2024 6.01%
Dec 31, 2023 6.98%
Sep 30, 2023 10.86%
Jun 30, 2023 17.13%
Mar 31, 2023 9.65%
Dec 31, 2022 23.51%
Sep 30, 2022 252.34%
Jun 30, 2022 228.92%
Mar 31, 2022 18.48%
Dec 31, 2021 26.92%
Sep 30, 2021 40.41%
Jun 30, 2021 20.58%
Mar 31, 2021 18.04%
Dec 31, 2020 19.85%
Sep 30, 2020 22.02%
Jun 30, 2020 11.01%
Mar 31, 2020 19.20%
Dec 31, 2019 50.28%
Sep 30, 2019 20.59%
Jun 30, 2019 7.60%
Mar 31, 2019 37.05%
Dec 31, 2018 22.20%
Sep 30, 2018 20.27%
Jun 30, 2018 7.07%
Mar 31, 2018 17.38%
Dec 31, 2017 22.39%
Sep 30, 2017 -63.79%
Jun 30, 2017 -61.62%
Mar 31, 2017 5.69%